Rapamycin for Cats — Feline Longevity Therapy

The cat you love is worth fighting for

Aging in cats is not a mystery anymore. The biology behind heart disease, kidney decline and cancer risk runs through one central pathway — and rapamycin is the most studied molecule we have for targeting it.

Why rapamycin for cats

• Heart — hypertrophic cardiomyopathy (HCM) is the most common heart disease in cats. Recent clinical research suggests rapamycin can slow its progression — a first for feline cardiology.
• Kidneys — chronic kidney disease affects most senior cats. mTOR inhibition is under active clinical investigation at veterinary schools.
• Cancer risk — documented benefit signals in feline mammary and squamous cell carcinomas.
• Cellular aging — partial mTOR inhibition activates autophagy, the cell’s cleanup process, reducing systemic inflammation.

How the therapy works

One delayed-release, acid-resistant tablet once a week, with food. Dosing is calibrated to your cat’s body weight (0.5 mg, 1.0 mg or 2.0 mg strengths). Flavored oral suspensions — chicken, fish, beef — are available for cats that refuse tablets.

Veterinary oversight, included

This is a veterinarian-directed therapy program. Every Rapavie order includes a licensed veterinarian’s review of your cat’s health history, personalized dosing, and ongoing monitoring guidance. Medication is dispensed under veterinary prescription. Lab-tested to a 99.9% purity standard.